RxDoctor Payments Data

Sara Zettervall, MD

Vascular Surgery · Seattle, WANPI 1710270152

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $81,580 of the $125,757 with a category attached, or 64.9%. 11 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 57.8% of the total. 2025 is the largest year on record at $58,892, more than ten times the $2,093 reported in 2019. Among vascular surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$125,757in general payments, 2019–2025

Across 210 payments — averaging $598.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$73K
  • Cook Incorporated$28K
  • Bolton Medical Inc$12K
  • Medtronic$6K
  • Cook Medical LLC$4K
  • Wilson Cook Medical Incorporated$2K
  • plus $2K from 5 others
$16,675in research payments, 2019–2025

Across 3 payments — averaging $5558.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cook Research Incorporated$17K

What the payments were for

  • Consulting fees$81,58065%
  • Speaking & faculty fees$12,10810%
  • Grants$2,7222%
  • Travel & lodging$18,31715%
  • Food & beverage$8,8147%
  • Education$2,2162%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,757 in reported general payments places this provider in the 95th percentile of 111 vascular surgery providers in Washington.

See all vascular surgery providers in Washington

Medicare billing

Part B allowed, 2024
$84,355
Medicare patients
341
Services billed
666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →